Published Date:2025-04-23 Original Link:https://www.onenessbio.com/en/news_detail354_2.htm No 1 Date of announcement 2025/04/23 Time of announcement 17:46:40 Subject The medical device registration application of Bonvadis for all indications in wounds has been accepted by Egypt EDA. To which item it meets Subparagraph 10 Date of events 2025/04/23 Statement 1. Date of occurrence of the event:2025/04/23 2. New drug...Read More
Published Date:2025-04-21 Original Link:https://www.onenessbio.com/en/news_detail347_2.htm No 1 Date of announcement 2025/04/21 Time of announcement 16:50:20 Subject Oneness announces information about the first investor conference in 2025. To which item it meets paragraph 12 Date of events 2025/04/28 Statement Date of institutional investor conference: 2025/04/28 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor conference:...Read More
Published Date:2025-04-16 Original Link:https://www.onenessbio.com/en/news_detail353_2.htm No 1 Date of announcement 2025/04/16 Time of announcement 22:02:17 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by Australia TGA. To which item it meets Subparagraph 10 Date of events 2025/04/16 Statement 1. Date of occurrence of the event:2025/04/16 2. New drug...Read More
Published Date:2025-04-10 Original Link:https://www.onenessbio.com/en/news_detail352_2.htm No 3 Date of announcement 2025/04/10 Time of announcement 16:57:27 Subject Oneness has submitted 510(k) application of Bonvadis for full thickness wound indications to the U.S. FDA To which item it meets Subparagraph 10 Date of events 2025/04/10 Statement 1. Date of occurrence of the event:2025/04/10 2. New drug name or...Read More
Published Date:2025-04-10 Original Link:https://www.onenessbio.com/en/news_detail351_2.htm No 2 Date of announcement 2025/04/10 Time of announcement 16:45:21 Subject Announcement for the Board of Directors’ resolution to dispose of (sublease) part of a right-of-use assets to a related party. To which item it meets paragraph 20 Date of events 2025/04/10 Statement 1.Name and nature of the underlying asset (e.g.,...Read More
Published Date:2025-04-10 Original Link:https://www.onenessbio.com/en/news_detail350_2.htm No 1 Date of announcement 2025/04/10 Time of announcement 16:43:17 Subject Announcement for the Board of Directors’ resolution to acquire part of a right-of-use assets to a related party. To which item it meets paragraph 20 Date of events 2025/04/10 Statement 1.Name and nature of the underlying asset (e.g., land located...Read More
Published Date:2025-04-03 Original Link:https://www.onenessbio.com/en/news_detail346_2.htm No 1 Date of announcement 2025/04/03 Time of announcement 18:57:12 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by Brazil ANVISA. To which item it meets Subparagraph 10 Date of events 2025/04/03 Statement 1. Date of occurrence of the event:2025/04/03 2. New drug...Read More
Published Date:2025-03-25 Original Link:https://www.onenessbio.com/en/news_detail345_2.htm No 1 Date of announcement 2025/03/25 Time of announcement 20:52:20 Subject Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA. To which item it meets Subparagraph 53 Date of events 2025/03/25 Statement Date of occurrence of the event: 2025/03/25 Company Name:...Read More
Published Date:2025-03-18 Original Link:https://www.onenessbio.com/en/news_detail344_2.htm No 1 Date of announcement 2025/03/18 Time of announcement 18:01:39 Subject The medical device registration application of Bonvadis for all indications in wounds has been accepted by UAE MOHAP To which item it meets paragraph 10 Date of events 2025/03/18 Statement Date of occurrence of the event: 2025/03/18 New drug name...Read More
Published Date:2025-02-27 Original Link:https://www.onenessbio.com/en/news_detail343_2.htm No 3 Date of announcement 2025/02/27 Time of announcement 17:12:37 Subject Oneness Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2025. To which item it meets paragraph 17 Date of events 2025/02/27 Statement Date of the board of directors resolution: 2025/02/27 General shareholders’ meeting date: 2025/05/22 General shareholders’...Read More
